
Information
Paris, July 07, 2004
Press Release
New successes in hospital sterilization in Italy and Spain
Omasa, an Air Liquide Sante subsidiary and European leader in the outsourced supply of sterilization services to
hospitals and clinics, has just been awarded several major contracts, notably in Italy and Spain, representing overall sales of 2 million euros a
year starting in 2005.
In Italy, Omasa signed a seven-year contract with the Agostino Gemelli Polyclinic to supply a new sterilization plant
for the renowned hospital's multipurpose platform. The Gemelli Hospital, with 1,500 beds and 29 operating theaters, performs 22,000 surgeries and records
58,000 hospitalizations a year.
The new plant will have a staff of 22 employees and operate around the clock 365 days a year. It will house 96,000 steam sterilization units and 400 ethylene oxide
sterilization units.
In Spain, the new Murcia Hospital General Universitario signed a 2-year renewable contract making Omasa responsible for sterilization of
all the hospital's instruments. Currently under construction, the institution will house 289 beds and numerous operating theaters. Twelve full-time employees will work in the
sterilization unit. Omasa already has sterilization contracts with the Red Cross Hospital in Madrid and the Hospital del Oriente de Asturias.
Referring to these new developments in hygiene, Jean-Marc de Royere, President of Air Liquide Health and a member of the Group's Executive Committee, stated: "By
putting their trust in us, these top-ranked establishments are recognizing our commitment to serving patients each and every day. At Omasa, we are constantly developing solutions to
ensure optimal hygiene, which is essential to the health of both caregivers and patients."
Air Liquide Sante has 6,000 associates in 40 countries and achieved sales of 1.3 billion euros in 2003, a third of which came from hygiene activities.
******************
Present in 65 countries, Air Liquide is the qorld leader in industrial and medical gases and related services.
The Group offers innovative solutions based on constantly enhanced technologies. These solutions, which are in line with
Air Liquide's commitment to sustainable development, help to protect life and enable our customers to manufacture meny indispensable
everyday products. Founded in 1902, Air Liquide has more than 31,900 employees. The Group has successfully developed a long-term relationship with its
shareholders built on confidence and transparency and guided by the principles of corporate governance. Sales in 2003
totaled 8,394 million euros, of which sales outside France accounted almost 80%. Ait Liquide is listed on the Euronext Paris stock exchange and is a
component of the CAC 40 and EuroStoxx 50 indexes (ISIN code FR 0000120073).
For further information, please contact:
| Investor Relations |
Corporate Communication |
| Matthieu Baumgartner |
+33 (0)1 40 62 55 19 |
Dominique Maire |
+33(0)1 40 62 53 56 |
| Caroline Morand |
+33(01) 40 62 55 41 |
Joelle Ambon |
+33(0)1 40 62 51 31 |
www.airliquide.gr